Global Inactivated Polio and Rabies Vaccines Market Research Report 2023
Polio vaccines can be classified into two types: the inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. Rabies virus is transferred to humans through the saliva of an animal who is infected by it. Inactivated rabies virus (IRV) is injected before or after the infection of the virus in 1 ml doses having 2.5 IU per ml of rabies virus antigen.
According to QYResearch’s new survey, global Inactivated Polio and Rabies Vaccines market is projected to reach US$ 1051 million in 2029, increasing from US$ 635 million in 2022, with the CAGR of 7.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Inactivated Polio and Rabies Vaccines market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Inactivated Polio and Rabies Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Inactivated Polio and Rabies Vaccines market is projected to reach US$ 1051 million in 2029, increasing from US$ 635 million in 2022, with the CAGR of 7.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Inactivated Polio and Rabies Vaccines market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Inactivated Polio and Rabies Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Bharat Biotech
- BIO-MED
- Serum Institute of India
- Kedrion Biopharma
- GlaxoSmithKline
- Merck
- Pfizer
- Inactivated Polio Vaccine
- Inactivated Rabies Vaccine
- Pediatrics
- Adults
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 INACTIVATED POLIO AND RABIES VACCINES MARKET OVERVIEW
1.1 Product Overview and Scope of Inactivated Polio and Rabies Vaccines
1.2 Inactivated Polio and Rabies Vaccines Segment by Type
1.2.1 Global Inactivated Polio and Rabies Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 Inactivated Polio Vaccine
1.2.3 Inactivated Rabies Vaccine
1.3 Inactivated Polio and Rabies Vaccines Segment by Application
1.3.1 Global Inactivated Polio and Rabies Vaccines Market Value by Application: (2023-2029)
1.3.2 Pediatrics
1.3.3 Adults
1.4 Global Inactivated Polio and Rabies Vaccines Market Size Estimates and Forecasts
1.4.1 Global Inactivated Polio and Rabies Vaccines Revenue 2018-2029
1.4.2 Global Inactivated Polio and Rabies Vaccines Sales 2018-2029
1.4.3 Global Inactivated Polio and Rabies Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 INACTIVATED POLIO AND RABIES VACCINES MARKET COMPETITION BY MANUFACTURERS
2.1 Global Inactivated Polio and Rabies Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Inactivated Polio and Rabies Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Inactivated Polio and Rabies Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Inactivated Polio and Rabies Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inactivated Polio and Rabies Vaccines, Product Type & Application
2.7 Inactivated Polio and Rabies Vaccines Market Competitive Situation and Trends
2.7.1 Inactivated Polio and Rabies Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inactivated Polio and Rabies Vaccines Players Market Share by Revenue
2.7.3 Global Inactivated Polio and Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 INACTIVATED POLIO AND RABIES VACCINES RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Inactivated Polio and Rabies Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Inactivated Polio and Rabies Vaccines Global Inactivated Polio and Rabies Vaccines Sales by Region: 2018-2029
3.2.1 Global Inactivated Polio and Rabies Vaccines Sales by Region: 2018-2023
3.2.2 Global Inactivated Polio and Rabies Vaccines Sales by Region: 2024-2029
3.3 Global Inactivated Polio and Rabies Vaccines Global Inactivated Polio and Rabies Vaccines Revenue by Region: 2018-2029
3.3.1 Global Inactivated Polio and Rabies Vaccines Revenue by Region: 2018-2023
3.3.2 Global Inactivated Polio and Rabies Vaccines Revenue by Region: 2024-2029
3.4 North America Inactivated Polio and Rabies Vaccines Market Facts & Figures by Country
3.4.1 North America Inactivated Polio and Rabies Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Inactivated Polio and Rabies Vaccines Sales by Country (2018-2029)
3.4.3 North America Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inactivated Polio and Rabies Vaccines Market Facts & Figures by Country
3.5.1 Europe Inactivated Polio and Rabies Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Inactivated Polio and Rabies Vaccines Sales by Country (2018-2029)
3.5.3 Europe Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inactivated Polio and Rabies Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Inactivated Polio and Rabies Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Inactivated Polio and Rabies Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Inactivated Polio and Rabies Vaccines Market Facts & Figures by Country
3.7.1 Latin America Inactivated Polio and Rabies Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Inactivated Polio and Rabies Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inactivated Polio and Rabies Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Inactivated Polio and Rabies Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Inactivated Polio and Rabies Vaccines Sales by Type (2018-2029)
4.1.1 Global Inactivated Polio and Rabies Vaccines Sales by Type (2018-2023)
4.1.2 Global Inactivated Polio and Rabies Vaccines Sales by Type (2024-2029)
4.1.3 Global Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Inactivated Polio and Rabies Vaccines Revenue by Type (2018-2029)
4.2.1 Global Inactivated Polio and Rabies Vaccines Revenue by Type (2018-2023)
4.2.2 Global Inactivated Polio and Rabies Vaccines Revenue by Type (2024-2029)
4.2.3 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Inactivated Polio and Rabies Vaccines Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Inactivated Polio and Rabies Vaccines Sales by Application (2018-2029)
5.1.1 Global Inactivated Polio and Rabies Vaccines Sales by Application (2018-2023)
5.1.2 Global Inactivated Polio and Rabies Vaccines Sales by Application (2024-2029)
5.1.3 Global Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Inactivated Polio and Rabies Vaccines Revenue by Application (2018-2029)
5.2.1 Global Inactivated Polio and Rabies Vaccines Revenue by Application (2018-2023)
5.2.2 Global Inactivated Polio and Rabies Vaccines Revenue by Application (2024-2029)
5.2.3 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Inactivated Polio and Rabies Vaccines Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Bharat Biotech
6.1.1 Bharat Biotech Corporation Information
6.1.2 Bharat Biotech Description and Business Overview
6.1.3 Bharat Biotech Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bharat Biotech Inactivated Polio and Rabies Vaccines Product Portfolio
6.1.5 Bharat Biotech Recent Developments/Updates
6.2 BIO-MED
6.2.1 BIO-MED Corporation Information
6.2.2 BIO-MED Description and Business Overview
6.2.3 BIO-MED Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BIO-MED Inactivated Polio and Rabies Vaccines Product Portfolio
6.2.5 BIO-MED Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Corporation Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Serum Institute of India Inactivated Polio and Rabies Vaccines Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 Kedrion Biopharma
6.4.1 Kedrion Biopharma Corporation Information
6.4.2 Kedrion Biopharma Description and Business Overview
6.4.3 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product Portfolio
6.4.5 Kedrion Biopharma Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Merck Inactivated Polio and Rabies Vaccines Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Inactivated Polio and Rabies Vaccines Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Inactivated Polio and Rabies Vaccines Industry Chain Analysis
7.2 Inactivated Polio and Rabies Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inactivated Polio and Rabies Vaccines Production Mode & Process
7.4 Inactivated Polio and Rabies Vaccines Sales and Marketing
7.4.1 Inactivated Polio and Rabies Vaccines Sales Channels
7.4.2 Inactivated Polio and Rabies Vaccines Distributors
7.5 Inactivated Polio and Rabies Vaccines Customers
8 INACTIVATED POLIO AND RABIES VACCINES MARKET DYNAMICS
8.1 Inactivated Polio and Rabies Vaccines Industry Trends
8.2 Inactivated Polio and Rabies Vaccines Market Drivers
8.3 Inactivated Polio and Rabies Vaccines Market Challenges
8.4 Inactivated Polio and Rabies Vaccines Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Inactivated Polio and Rabies Vaccines
1.2 Inactivated Polio and Rabies Vaccines Segment by Type
1.2.1 Global Inactivated Polio and Rabies Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 Inactivated Polio Vaccine
1.2.3 Inactivated Rabies Vaccine
1.3 Inactivated Polio and Rabies Vaccines Segment by Application
1.3.1 Global Inactivated Polio and Rabies Vaccines Market Value by Application: (2023-2029)
1.3.2 Pediatrics
1.3.3 Adults
1.4 Global Inactivated Polio and Rabies Vaccines Market Size Estimates and Forecasts
1.4.1 Global Inactivated Polio and Rabies Vaccines Revenue 2018-2029
1.4.2 Global Inactivated Polio and Rabies Vaccines Sales 2018-2029
1.4.3 Global Inactivated Polio and Rabies Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 INACTIVATED POLIO AND RABIES VACCINES MARKET COMPETITION BY MANUFACTURERS
2.1 Global Inactivated Polio and Rabies Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Inactivated Polio and Rabies Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Inactivated Polio and Rabies Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Inactivated Polio and Rabies Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inactivated Polio and Rabies Vaccines, Product Type & Application
2.7 Inactivated Polio and Rabies Vaccines Market Competitive Situation and Trends
2.7.1 Inactivated Polio and Rabies Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inactivated Polio and Rabies Vaccines Players Market Share by Revenue
2.7.3 Global Inactivated Polio and Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 INACTIVATED POLIO AND RABIES VACCINES RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Inactivated Polio and Rabies Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Inactivated Polio and Rabies Vaccines Global Inactivated Polio and Rabies Vaccines Sales by Region: 2018-2029
3.2.1 Global Inactivated Polio and Rabies Vaccines Sales by Region: 2018-2023
3.2.2 Global Inactivated Polio and Rabies Vaccines Sales by Region: 2024-2029
3.3 Global Inactivated Polio and Rabies Vaccines Global Inactivated Polio and Rabies Vaccines Revenue by Region: 2018-2029
3.3.1 Global Inactivated Polio and Rabies Vaccines Revenue by Region: 2018-2023
3.3.2 Global Inactivated Polio and Rabies Vaccines Revenue by Region: 2024-2029
3.4 North America Inactivated Polio and Rabies Vaccines Market Facts & Figures by Country
3.4.1 North America Inactivated Polio and Rabies Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Inactivated Polio and Rabies Vaccines Sales by Country (2018-2029)
3.4.3 North America Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inactivated Polio and Rabies Vaccines Market Facts & Figures by Country
3.5.1 Europe Inactivated Polio and Rabies Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Inactivated Polio and Rabies Vaccines Sales by Country (2018-2029)
3.5.3 Europe Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inactivated Polio and Rabies Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Inactivated Polio and Rabies Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Inactivated Polio and Rabies Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Inactivated Polio and Rabies Vaccines Market Facts & Figures by Country
3.7.1 Latin America Inactivated Polio and Rabies Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Inactivated Polio and Rabies Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inactivated Polio and Rabies Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Inactivated Polio and Rabies Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Inactivated Polio and Rabies Vaccines Sales by Type (2018-2029)
4.1.1 Global Inactivated Polio and Rabies Vaccines Sales by Type (2018-2023)
4.1.2 Global Inactivated Polio and Rabies Vaccines Sales by Type (2024-2029)
4.1.3 Global Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Inactivated Polio and Rabies Vaccines Revenue by Type (2018-2029)
4.2.1 Global Inactivated Polio and Rabies Vaccines Revenue by Type (2018-2023)
4.2.2 Global Inactivated Polio and Rabies Vaccines Revenue by Type (2024-2029)
4.2.3 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Inactivated Polio and Rabies Vaccines Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Inactivated Polio and Rabies Vaccines Sales by Application (2018-2029)
5.1.1 Global Inactivated Polio and Rabies Vaccines Sales by Application (2018-2023)
5.1.2 Global Inactivated Polio and Rabies Vaccines Sales by Application (2024-2029)
5.1.3 Global Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Inactivated Polio and Rabies Vaccines Revenue by Application (2018-2029)
5.2.1 Global Inactivated Polio and Rabies Vaccines Revenue by Application (2018-2023)
5.2.2 Global Inactivated Polio and Rabies Vaccines Revenue by Application (2024-2029)
5.2.3 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Inactivated Polio and Rabies Vaccines Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Bharat Biotech
6.1.1 Bharat Biotech Corporation Information
6.1.2 Bharat Biotech Description and Business Overview
6.1.3 Bharat Biotech Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bharat Biotech Inactivated Polio and Rabies Vaccines Product Portfolio
6.1.5 Bharat Biotech Recent Developments/Updates
6.2 BIO-MED
6.2.1 BIO-MED Corporation Information
6.2.2 BIO-MED Description and Business Overview
6.2.3 BIO-MED Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BIO-MED Inactivated Polio and Rabies Vaccines Product Portfolio
6.2.5 BIO-MED Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Corporation Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Serum Institute of India Inactivated Polio and Rabies Vaccines Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 Kedrion Biopharma
6.4.1 Kedrion Biopharma Corporation Information
6.4.2 Kedrion Biopharma Description and Business Overview
6.4.3 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product Portfolio
6.4.5 Kedrion Biopharma Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Merck Inactivated Polio and Rabies Vaccines Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Inactivated Polio and Rabies Vaccines Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Inactivated Polio and Rabies Vaccines Industry Chain Analysis
7.2 Inactivated Polio and Rabies Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inactivated Polio and Rabies Vaccines Production Mode & Process
7.4 Inactivated Polio and Rabies Vaccines Sales and Marketing
7.4.1 Inactivated Polio and Rabies Vaccines Sales Channels
7.4.2 Inactivated Polio and Rabies Vaccines Distributors
7.5 Inactivated Polio and Rabies Vaccines Customers
8 INACTIVATED POLIO AND RABIES VACCINES MARKET DYNAMICS
8.1 Inactivated Polio and Rabies Vaccines Industry Trends
8.2 Inactivated Polio and Rabies Vaccines Market Drivers
8.3 Inactivated Polio and Rabies Vaccines Market Challenges
8.4 Inactivated Polio and Rabies Vaccines Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Inactivated Polio and Rabies Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Inactivated Polio and Rabies Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Inactivated Polio and Rabies Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Inactivated Polio and Rabies Vaccines Sales (K Dose) of Key Manufacturers (2018-2023)
Table 5. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Inactivated Polio and Rabies Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Inactivated Polio and Rabies Vaccines Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Inactivated Polio and Rabies Vaccines Average Price (US$/Dose) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Inactivated Polio and Rabies Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Inactivated Polio and Rabies Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inactivated Polio and Rabies Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Inactivated Polio and Rabies Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inactivated Polio and Rabies Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio and Rabies Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inactivated Polio and Rabies Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Inactivated Polio and Rabies Vaccines Sales by Region (2018-2023) & (K Dose)
Table 18. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Region (2018-2023)
Table 19. Global Inactivated Polio and Rabies Vaccines Sales by Region (2024-2029) & (K Dose)
Table 20. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global Inactivated Polio and Rabies Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2018-2023)
Table 23. Global Inactivated Polio and Rabies Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America Inactivated Polio and Rabies Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Inactivated Polio and Rabies Vaccines Sales by Country (2018-2023) & (K Dose)
Table 27. North America Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (K Dose)
Table 28. North America Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Inactivated Polio and Rabies Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Inactivated Polio and Rabies Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Inactivated Polio and Rabies Vaccines Sales by Country (2018-2023) & (K Dose)
Table 32. Europe Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (K Dose)
Table 33. Europe Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Inactivated Polio and Rabies Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Inactivated Polio and Rabies Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Inactivated Polio and Rabies Vaccines Sales by Region (2018-2023) & (K Dose)
Table 37. Asia Pacific Inactivated Polio and Rabies Vaccines Sales by Region (2024-2029) & (K Dose)
Table 38. Asia Pacific Inactivated Polio and Rabies Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Inactivated Polio and Rabies Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Inactivated Polio and Rabies Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Inactivated Polio and Rabies Vaccines Sales by Country (2018-2023) & (K Dose)
Table 42. Latin America Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (K Dose)
Table 43. Latin America Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Inactivated Polio and Rabies Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Inactivated Polio and Rabies Vaccines Sales by Country (2018-2023) & (K Dose)
Table 47. Middle East & Africa Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (K Dose)
Table 48. Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Inactivated Polio and Rabies Vaccines Sales (K Dose) by Type (2018-2023)
Table 51. Global Inactivated Polio and Rabies Vaccines Sales (K Dose) by Type (2024-2029)
Table 52. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2018-2023)
Table 53. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global Inactivated Polio and Rabies Vaccines Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Inactivated Polio and Rabies Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2018-2023)
Table 57. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global Inactivated Polio and Rabies Vaccines Price (US$/Dose) by Type (2018-2023)
Table 59. Global Inactivated Polio and Rabies Vaccines Price (US$/Dose) by Type (2024-2029)
Table 60. Global Inactivated Polio and Rabies Vaccines Sales (K Dose) by Application (2018-2023)
Table 61. Global Inactivated Polio and Rabies Vaccines Sales (K Dose) by Application (2024-2029)
Table 62. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2018-2023)
Table 63. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global Inactivated Polio and Rabies Vaccines Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Inactivated Polio and Rabies Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2018-2023)
Table 67. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global Inactivated Polio and Rabies Vaccines Price (US$/Dose) by Application (2018-2023)
Table 69. Global Inactivated Polio and Rabies Vaccines Price (US$/Dose) by Application (2024-2029)
Table 70. Bharat Biotech Corporation Information
Table 71. Bharat Biotech Description and Business Overview
Table 72. Bharat Biotech Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 73. Bharat Biotech Inactivated Polio and Rabies Vaccines Product
Table 74. Bharat Biotech Recent Developments/Updates
Table 75. BIO-MED Corporation Information
Table 76. BIO-MED Description and Business Overview
Table 77. BIO-MED Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 78. BIO-MED Inactivated Polio and Rabies Vaccines Product
Table 79. BIO-MED Recent Developments/Updates
Table 80. Serum Institute of India Corporation Information
Table 81. Serum Institute of India Description and Business Overview
Table 82. Serum Institute of India Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 83. Serum Institute of India Inactivated Polio and Rabies Vaccines Product
Table 84. Serum Institute of India Recent Developments/Updates
Table 85. Kedrion Biopharma Corporation Information
Table 86. Kedrion Biopharma Description and Business Overview
Table 87. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 88. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product
Table 89. Kedrion Biopharma Recent Developments/Updates
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 93. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product
Table 94. GlaxoSmithKline Recent Developments/Updates
Table 95. Merck Corporation Information
Table 96. Merck Description and Business Overview
Table 97. Merck Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 98. Merck Inactivated Polio and Rabies Vaccines Product
Table 99. Merck Recent Developments/Updates
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 103. Pfizer Inactivated Polio and Rabies Vaccines Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Inactivated Polio and Rabies Vaccines Distributors List
Table 108. Inactivated Polio and Rabies Vaccines Customers List
Table 109. Inactivated Polio and Rabies Vaccines Market Trends
Table 110. Inactivated Polio and Rabies Vaccines Market Drivers
Table 111. Inactivated Polio and Rabies Vaccines Market Challenges
Table 112. Inactivated Polio and Rabies Vaccines Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 1. Global Inactivated Polio and Rabies Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Inactivated Polio and Rabies Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Inactivated Polio and Rabies Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Inactivated Polio and Rabies Vaccines Sales (K Dose) of Key Manufacturers (2018-2023)
Table 5. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Inactivated Polio and Rabies Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Inactivated Polio and Rabies Vaccines Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Inactivated Polio and Rabies Vaccines Average Price (US$/Dose) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Inactivated Polio and Rabies Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Inactivated Polio and Rabies Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inactivated Polio and Rabies Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Inactivated Polio and Rabies Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inactivated Polio and Rabies Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio and Rabies Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inactivated Polio and Rabies Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Inactivated Polio and Rabies Vaccines Sales by Region (2018-2023) & (K Dose)
Table 18. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Region (2018-2023)
Table 19. Global Inactivated Polio and Rabies Vaccines Sales by Region (2024-2029) & (K Dose)
Table 20. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global Inactivated Polio and Rabies Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2018-2023)
Table 23. Global Inactivated Polio and Rabies Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America Inactivated Polio and Rabies Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Inactivated Polio and Rabies Vaccines Sales by Country (2018-2023) & (K Dose)
Table 27. North America Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (K Dose)
Table 28. North America Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Inactivated Polio and Rabies Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Inactivated Polio and Rabies Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Inactivated Polio and Rabies Vaccines Sales by Country (2018-2023) & (K Dose)
Table 32. Europe Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (K Dose)
Table 33. Europe Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Inactivated Polio and Rabies Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Inactivated Polio and Rabies Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Inactivated Polio and Rabies Vaccines Sales by Region (2018-2023) & (K Dose)
Table 37. Asia Pacific Inactivated Polio and Rabies Vaccines Sales by Region (2024-2029) & (K Dose)
Table 38. Asia Pacific Inactivated Polio and Rabies Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Inactivated Polio and Rabies Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Inactivated Polio and Rabies Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Inactivated Polio and Rabies Vaccines Sales by Country (2018-2023) & (K Dose)
Table 42. Latin America Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (K Dose)
Table 43. Latin America Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Inactivated Polio and Rabies Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Inactivated Polio and Rabies Vaccines Sales by Country (2018-2023) & (K Dose)
Table 47. Middle East & Africa Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (K Dose)
Table 48. Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Inactivated Polio and Rabies Vaccines Sales (K Dose) by Type (2018-2023)
Table 51. Global Inactivated Polio and Rabies Vaccines Sales (K Dose) by Type (2024-2029)
Table 52. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2018-2023)
Table 53. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global Inactivated Polio and Rabies Vaccines Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Inactivated Polio and Rabies Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2018-2023)
Table 57. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global Inactivated Polio and Rabies Vaccines Price (US$/Dose) by Type (2018-2023)
Table 59. Global Inactivated Polio and Rabies Vaccines Price (US$/Dose) by Type (2024-2029)
Table 60. Global Inactivated Polio and Rabies Vaccines Sales (K Dose) by Application (2018-2023)
Table 61. Global Inactivated Polio and Rabies Vaccines Sales (K Dose) by Application (2024-2029)
Table 62. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2018-2023)
Table 63. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global Inactivated Polio and Rabies Vaccines Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Inactivated Polio and Rabies Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2018-2023)
Table 67. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global Inactivated Polio and Rabies Vaccines Price (US$/Dose) by Application (2018-2023)
Table 69. Global Inactivated Polio and Rabies Vaccines Price (US$/Dose) by Application (2024-2029)
Table 70. Bharat Biotech Corporation Information
Table 71. Bharat Biotech Description and Business Overview
Table 72. Bharat Biotech Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 73. Bharat Biotech Inactivated Polio and Rabies Vaccines Product
Table 74. Bharat Biotech Recent Developments/Updates
Table 75. BIO-MED Corporation Information
Table 76. BIO-MED Description and Business Overview
Table 77. BIO-MED Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 78. BIO-MED Inactivated Polio and Rabies Vaccines Product
Table 79. BIO-MED Recent Developments/Updates
Table 80. Serum Institute of India Corporation Information
Table 81. Serum Institute of India Description and Business Overview
Table 82. Serum Institute of India Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 83. Serum Institute of India Inactivated Polio and Rabies Vaccines Product
Table 84. Serum Institute of India Recent Developments/Updates
Table 85. Kedrion Biopharma Corporation Information
Table 86. Kedrion Biopharma Description and Business Overview
Table 87. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 88. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product
Table 89. Kedrion Biopharma Recent Developments/Updates
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 93. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product
Table 94. GlaxoSmithKline Recent Developments/Updates
Table 95. Merck Corporation Information
Table 96. Merck Description and Business Overview
Table 97. Merck Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 98. Merck Inactivated Polio and Rabies Vaccines Product
Table 99. Merck Recent Developments/Updates
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 103. Pfizer Inactivated Polio and Rabies Vaccines Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Inactivated Polio and Rabies Vaccines Distributors List
Table 108. Inactivated Polio and Rabies Vaccines Customers List
Table 109. Inactivated Polio and Rabies Vaccines Market Trends
Table 110. Inactivated Polio and Rabies Vaccines Market Drivers
Table 111. Inactivated Polio and Rabies Vaccines Market Challenges
Table 112. Inactivated Polio and Rabies Vaccines Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Inactivated Polio and Rabies Vaccines
Figure 2. Global Inactivated Polio and Rabies Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Inactivated Polio and Rabies Vaccines Market Share by Type in 2022 & 2029
Figure 4. Inactivated Polio Vaccine Product Picture
Figure 5. Inactivated Rabies Vaccine Product Picture
Figure 6. Global Inactivated Polio and Rabies Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Inactivated Polio and Rabies Vaccines Market Share by Application in 2022 & 2029
Figure 8. Pediatrics
Figure 9. Adults
Figure 10. Global Inactivated Polio and Rabies Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Inactivated Polio and Rabies Vaccines Market Size (2018-2029) & (US$ Million)
Figure 12. Global Inactivated Polio and Rabies Vaccines Sales (2018-2029) & (K Dose)
Figure 13. Global Inactivated Polio and Rabies Vaccines Average Price (US$/Dose) & (2018-2029)
Figure 14. Inactivated Polio and Rabies Vaccines Report Years Considered
Figure 15. Inactivated Polio and Rabies Vaccines Sales Share by Manufacturers in 2022
Figure 16. Global Inactivated Polio and Rabies Vaccines Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Inactivated Polio and Rabies Vaccines Players: Market Share by Revenue in 2022
Figure 18. Inactivated Polio and Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Inactivated Polio and Rabies Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2018-2029)
Figure 21. North America Inactivated Polio and Rabies Vaccines Revenue Market Share by Country (2018-2029)
Figure 22. United States Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2018-2029)
Figure 25. Europe Inactivated Polio and Rabies Vaccines Revenue Market Share by Country (2018-2029)
Figure 26. Germany Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Inactivated Polio and Rabies Vaccines Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2018-2029)
Figure 33. China Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2018-2029)
Figure 43. Latin America Inactivated Polio and Rabies Vaccines Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Inactivated Polio and Rabies Vaccines by Type (2018-2029)
Figure 53. Global Revenue Market Share of Inactivated Polio and Rabies Vaccines by Type (2018-2029)
Figure 54. Global Inactivated Polio and Rabies Vaccines Price (US$/Dose) by Type (2018-2029)
Figure 55. Global Sales Market Share of Inactivated Polio and Rabies Vaccines by Application (2018-2029)
Figure 56. Global Revenue Market Share of Inactivated Polio and Rabies Vaccines by Application (2018-2029)
Figure 57. Global Inactivated Polio and Rabies Vaccines Price (US$/Dose) by Application (2018-2029)
Figure 58. Inactivated Polio and Rabies Vaccines Value Chain
Figure 59. Inactivated Polio and Rabies Vaccines Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Figure 1. Product Picture of Inactivated Polio and Rabies Vaccines
Figure 2. Global Inactivated Polio and Rabies Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Inactivated Polio and Rabies Vaccines Market Share by Type in 2022 & 2029
Figure 4. Inactivated Polio Vaccine Product Picture
Figure 5. Inactivated Rabies Vaccine Product Picture
Figure 6. Global Inactivated Polio and Rabies Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Inactivated Polio and Rabies Vaccines Market Share by Application in 2022 & 2029
Figure 8. Pediatrics
Figure 9. Adults
Figure 10. Global Inactivated Polio and Rabies Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Inactivated Polio and Rabies Vaccines Market Size (2018-2029) & (US$ Million)
Figure 12. Global Inactivated Polio and Rabies Vaccines Sales (2018-2029) & (K Dose)
Figure 13. Global Inactivated Polio and Rabies Vaccines Average Price (US$/Dose) & (2018-2029)
Figure 14. Inactivated Polio and Rabies Vaccines Report Years Considered
Figure 15. Inactivated Polio and Rabies Vaccines Sales Share by Manufacturers in 2022
Figure 16. Global Inactivated Polio and Rabies Vaccines Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Inactivated Polio and Rabies Vaccines Players: Market Share by Revenue in 2022
Figure 18. Inactivated Polio and Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Inactivated Polio and Rabies Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2018-2029)
Figure 21. North America Inactivated Polio and Rabies Vaccines Revenue Market Share by Country (2018-2029)
Figure 22. United States Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2018-2029)
Figure 25. Europe Inactivated Polio and Rabies Vaccines Revenue Market Share by Country (2018-2029)
Figure 26. Germany Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Inactivated Polio and Rabies Vaccines Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2018-2029)
Figure 33. China Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2018-2029)
Figure 43. Latin America Inactivated Polio and Rabies Vaccines Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Inactivated Polio and Rabies Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Inactivated Polio and Rabies Vaccines by Type (2018-2029)
Figure 53. Global Revenue Market Share of Inactivated Polio and Rabies Vaccines by Type (2018-2029)
Figure 54. Global Inactivated Polio and Rabies Vaccines Price (US$/Dose) by Type (2018-2029)
Figure 55. Global Sales Market Share of Inactivated Polio and Rabies Vaccines by Application (2018-2029)
Figure 56. Global Revenue Market Share of Inactivated Polio and Rabies Vaccines by Application (2018-2029)
Figure 57. Global Inactivated Polio and Rabies Vaccines Price (US$/Dose) by Application (2018-2029)
Figure 58. Inactivated Polio and Rabies Vaccines Value Chain
Figure 59. Inactivated Polio and Rabies Vaccines Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
